Robert Eriksson

925 total citations
22 papers, 581 citations indexed

About

Robert Eriksson is a scholar working on Molecular Biology, Toxicology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert Eriksson has authored 22 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Toxicology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert Eriksson's work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Pharmaceutical studies and practices (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Robert Eriksson is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (6 papers), Pharmaceutical studies and practices (5 papers) and Pharmaceutical Practices and Patient Outcomes (4 papers). Robert Eriksson collaborates with scholars based in Denmark, Sweden and United States. Robert Eriksson's co-authors include Søren Brunak, Lars Juhl Jensen, Peter Bjødstrup Jensen, Tudor I. Oprea, Anders Boeck Jensen, Sabrina Gade Ellesøe, Pope Moseley, Henriette Schmock, Sune Pletscher-Frankild and Thomas Werge and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Robert Eriksson

22 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Eriksson Denmark	11	142	138	137	65	60	22	581
Aaron J. Masino United States	15	201 1.4×	130 0.9×	156 1.1×	85 1.3×	74 1.2×	44	801
Phung‐Anh Nguyen Taiwan	16	147 1.0×	64 0.5×	174 1.3×	163 2.5×	13 0.2×	47	945
Kenneth Lai United States	17	161 1.1×	99 0.7×	27 0.2×	83 1.3×	114 1.9×	27	762
Monica M. Horvath United States	14	52 0.4×	179 1.3×	70 0.5×	151 2.3×	27 0.5×	26	731
Joseph M. Plasek United States	13	127 0.9×	108 0.8×	38 0.3×	58 0.9×	81 1.4×	42	544
Foster Goss United States	19	141 1.0×	104 0.8×	63 0.5×	222 3.4×	214 3.6×	47	1.1k
Todd Ferris United States	9	178 1.3×	175 1.3×	65 0.5×	141 2.2×	68 1.1×	11	854
Sue Wood United States	6	79 0.6×	202 1.5×	86 0.6×	13 0.2×	326 5.4×	14	1.1k
Guillaume Bouzillé France	18	78 0.5×	70 0.5×	136 1.0×	79 1.2×	27 0.5×	86	793
Ania Syrowatka United States	12	59 0.4×	28 0.2×	37 0.3×	67 1.0×	34 0.6×	34	729

Countries citing papers authored by Robert Eriksson

Since Specialization

Citations

This map shows the geographic impact of Robert Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Eriksson more than expected).

Fields of papers citing papers by Robert Eriksson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Eriksson. The network helps show where Robert Eriksson may publish in the future.

Co-authorship network of co-authors of Robert Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Eriksson. A scholar is included among the top collaborators of Robert Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Eriksson. Robert Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eriksson, Robert, Helle Pedersen, Christian Simon, et al.. (2023). A unidirectional mapping of ICD-8 to ICD-10 codes, for harmonized longitudinal analysis of diseases. European Journal of Epidemiology. 38(10). 1043–1052. 8 indexed citations

Rodríguez, Cristina Leal, Amalie Dahl Haue, Gianluca Mazzoni, et al.. (2023). Drug dosage modifications in 24 million in-patient prescriptions covering eight years: A Danish population-wide study of polypharmacy. SHILAP Revista de lepidopterología. 2(9). e0000336–e0000336. 1 indexed citations

Frische, Anders, Charlotte Sværke Jørgensen, Lasse Dam Rasmussen, et al.. (2023). High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients. Virology Journal. 20(1). 14–14. 5 indexed citations

Rodríguez, Cristina Leal, Benjamin Skov Kaas‐Hansen, Robert Eriksson, et al.. (2022). Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes. Pharmacoepidemiology and Drug Safety. 31(6). 632–642. 12 indexed citations

Haue, Amalie Dahl, José Juan Almagro Armenteros, Robert Eriksson, et al.. (2022). Temporal patterns of multi-morbidity in 570157 ischemic heart disease patients: a nationwide cohort study. Cardiovascular Diabetology. 21(1). 87–87. 7 indexed citations

Ronit, Andreas, Sofie E. Jørgensen, Casper Roed, et al.. (2021). Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome. Frontiers in Immunology. 12. 718744–718744. 14 indexed citations

Holler, Jon Gitz, Robert Eriksson, Tomas Ø. Jensen, et al.. (2021). First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study. BMC Infectious Diseases. 21(1). 39–39. 26 indexed citations

Eriksson, Robert, et al.. (2020). Implementation and comparison of two text mining methods with a standard pharmacovigilance method for signal detection of medication errors. BMC Medical Informatics and Decision Making. 20(1). 94–94. 8 indexed citations

Brunak, Søren, et al.. (2020). Association between antipsychotic drug dose and length of clinical notes: a proxy of disease severity?. BMC Medical Research Methodology. 20(1). 107–107. 5 indexed citations

10.

Eriksson, Robert, et al.. (2020). Sex differences in text-mined possible adverse drug events associated with drugs for psychosis. Journal of Psychopharmacology. 34(5). 532–539. 11 indexed citations

11.

Eriksson, Robert, Brian V. Broberg, Pelle L. Ishøy, et al.. (2019). Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density. Frontiers in Psychiatry. 9. 781–781. 18 indexed citations

12.

Jensen, Anders Boeck, Pope Moseley, Tudor I. Oprea, et al.. (2014). Temporal disease trajectories condensed from population-wide registry data covering 6.2 million patients. Nature Communications. 5(1). 28–30. 257 indexed citations

13.

Eriksson, Robert, et al.. (2014). Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events. Frontiers in Physiology. 5. 332–332. 17 indexed citations

14.

Eriksson, Robert, et al.. (2014). Discrepancies in listed adverse drug reactions in pharmaceutical product information supplied by the regulatory authorities in Denmark and the USA. Pharmacology Research & Perspectives. 2(3). e00038–e00038. 23 indexed citations

15.

Eriksson, Robert, Thomas Werge, Lars Juhl Jensen, & Søren Brunak. (2014). Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population. Drug Safety. 37(4). 237–247. 41 indexed citations

16.

Eriksson, Robert, Peter Bjødstrup Jensen, Sune Pletscher-Frankild, Lars Juhl Jensen, & Søren Brunak. (2013). Dictionary construction and identification of possible adverse drug events in Danish clinical narrative text. Journal of the American Medical Informatics Association. 20(5). 947–953. 64 indexed citations

17.

Gustavsson, Bengt, et al.. (2005). A Test Method for Assessment of Spill and Leakage From Drug Preparation Systems. The Annals of Occupational Hygiene. 49(8). 711–8. 10 indexed citations

18.

Nygren, Olle, et al.. (2002). Exposure to anti-cancer drugs during preparation and administration. Investigations of an open and a closed system. Journal of Environmental Monitoring. 4(5). 739–742. 37 indexed citations

19.

Elfving, Peter, S. Colleen, Sverker Hellsten, et al.. (2000). The Effect of Isoniazid on BCG-Induced Toxicity in Patients with Superficial Bladder Cancer. European Urology. 37(Suppl. 1). 26–30. 10 indexed citations

20.

Alfredsson, Lars, et al.. (1982). Theophyllines three times daily - when are the doses actually taken? - Pharmacokinetic ideals versus clinical practice.. PubMed. 63(3). 234–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact